Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Genetic Duplication of Tissue Factor Leads to Partial Specialization of Function in Zebrafish

Steven Grzegorski, BA, Divyani Paul, BS, James H. Morrissey, PhD, Jordan A. Shavit, MD PhD

Blood (2019) 134 (Supplement_1): 486.

https://doi.org/10.1182/blood-2019-131980

Published: 2019

Journal Articles

Safety of Caplacizumab in Patients Without Documented Severe ADAMTS13 Deficiency During the HERCULES Study

Javier De La Rubia, Flora Peyvandi, MD PhD, Marie Scully, Spero Cataland, MD, Paul Coppo, MD PhD, Johanna A. Kremer Hovinga, MD Prof, Paul Knoebl, MD, Ara Metjian, MD, Katerina Pavenski, MD, Hilde De Winter, MD, Rui de Passos Sousa, Filip Callewaert

Blood (2019) 134 (Supplement_1): 1093.

https://doi.org/10.1182/blood-2019-124004

Published: 2019

Journal Articles

Antithrombotic Therapy Management in Patients with Inherited Bleeding Disorders and Ischaemic Heart Disease: A Single-Center Experience

Marie-Léa Piel-Julian, Marie-Françoise Thiercelin-Legrand, MD, Guillaume Moulis, MD PhD, Sophie Voisin, MD, Ségolène Claeyssens, Laurent Sailler, MD PhD

Blood (2018) 132 (Supplement 1): 1213.

https://doi.org/10.1182/blood-2018-99-117101

Published: 2018

Journal Articles

Factors Influencing Incidence of Supraventricular Arrhythmias during and after Autologous Stem Cell Transplant in Multiple Myeloma

Megan Sturdy, MD, Rebecca Ye, BA, Trevor L Jenkins, MD, James Driscoll, MD PhD, Paolo Caimi, MD, Leland Metheny, MD, Rachel Zebrowski, RN, Nicole Ferrari, Merle Kolk, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2018) 132 (Supplement 1): 4834.

https://doi.org/10.1182/blood-2018-99-113828

Published: 2018

Journal Articles

Comparative Effectiveness of Different Strategies for Monitoring Neonates on Extra Corporeal Membrane Oxygenation (ECMO)

Aditi Kamdar, MD, Natalie Rintoul, MD, David F. Friedman, MD, James T Connelly, BS, RRT-NPS, Holly Hedrick, Leslie Raffini, MD

Blood (2016) 128 (22): 1007.

https://doi.org/10.1182/blood.V128.22.1007.1007

Published: 2016

Journal Articles

Mantle cell lymphoma presenting as cardiac tamponade

Abhijeet Kumar, Soham Puvvada

Blood (2015) 126 (10): 1255.

https://doi.org/10.1182/blood-2015-03-626051

Published: 2015

Journal Articles

Rh-Positive Fresh Frozen Plasma (FFP) Therapy Can Induce Cross-Reactive Immune Response to Red Blood Cell (RBC) Self-Antigen in Rh-Negative Patients Having Existing Alloimmunization to Rh-Antigen D

Irma O. Szymanski, MD

Blood (2014) 124 (21): 5109.

https://doi.org/10.1182/blood.V124.21.5109.5109

Published: 2014

Journal Articles

Long-Term Outcome Of Adolescents and Young Adults (AYA) After Autologous Transplantation For Lymphoma; Single Center Experience With Bu-CY-VP16 Conditioning Therapy

Rabi Hanna, MD, Brian J. Bolwell, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Deepa Jagadeesh, MD, MPH, Hien K. Duong, MD, Brian T. Hill, MD, PhD, Kelly Cherni, RN, Christina Ferraro, RN, Gina Green, RN, Betty K. Hamilton, MD, Lisa Rybicki, MS, Matt Kalaycio, MD

Blood (2013) 122 (21): 4644.

https://doi.org/10.1182/blood.V122.21.4644.4644

Published: 2013

Journal Articles

Rare Blast Phase (BP) Phenotypes of Chronic Myeloid Leukemia (CML)

Hady Ghanem, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD, Alfonso Quintás-Cardama, MD

Blood (2012) 120 (21): 4434.

https://doi.org/10.1182/blood.V120.21.4434.4434

Published: 2012

Journal Articles

Cytarabine Induced Pericardial Tamponade

Amit A. Patel, MD, Alison Mainardi, MD, Mala Varma, MD, Gabriel Sara, MD

Blood (2011) 118 (21): 4298.

https://doi.org/10.1182/blood.V118.21.4298.4298

Published: 2011

Journal Articles

Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP).

Terry Gernsheimer, MD, David J. Kuter, MD, DPhil, Douglas B. Cines, MD, Roberto Stasi, Mathias J. Rummel, MD, PhD, Bertrand Godeau, MD, Matthew Guo, PhD, Janet Franklin, MD, MPH

Blood (2010) 116 (21): 3701.

https://doi.org/10.1182/blood.V116.21.3701.3701

Published: 2010

Journal Articles

Clinical Development of MGCD0103, An Isotype-Selective HDAC Inhibitor: Pericarditis/Pericardial Effusion in the Context of Overall Safety and Efficacy.

Robert E. Martell, MD, PhD, Guillermo Garcia-Manero, MD, Anas Younes, MD, Michael Ewer, MD, Iyad N Daher, MD, Michel Drouin, MD, FRCP(C), Wendy Hunt, Karine Lortie, Jennifer Wilhelm, Jeffrey M. Besterman, PhD

Blood (2009) 114 (22): 4756.

https://doi.org/10.1182/blood.V114.22.4756.4756

Published: 2009

Journal Articles

Romidepsin (depsipeptide) Induces Clinically Significant Responses in Treatment-Refractory CTCL: An International, Multicenter Study.

Youn H. Kim, MD, Sunil Reddy, MD, Ellen J. Kim, MD, Alain H. Rook, MD, Adam Lerner, MD, Mariefrance Demierre, MD, Madeleine Duvic, MD, Sean Whittaker, MD, FRCP, Tadeusz Robak, MD, Jurgen C. Becker, MD, William McCulloch, MB, FRCP, Archibald G. Prentice, MB, FRCP, FRCPath, on behalf of All Investigators

Blood (2007) 110 (11): 123.

https://doi.org/10.1182/blood.V110.11.123.123

Published: 2007

Journal Articles

T Cell Blast Phase (T-BP) of Chronic Myelogenous Leuikemia (CML).

Alfonso Quintás-Cardama, MD, Hagop Kantarjian, M.D., Jorge Cortes, M.D.

Blood (2007) 110 (11): 4560.

https://doi.org/10.1182/blood.V110.11.4560.4560

Published: 2007

Journal Articles

Megakaryocytic Blast Phase (M-BP) of Chronic Myelogenous Leukemia (CML).

Alfonso Quintás-Cardama, MD, Hagop Kantarjian, M.D., Jorge Cortes, M.D.

Blood (2007) 110 (11): 4563.

https://doi.org/10.1182/blood.V110.11.4563.4563

Published: 2007

Journal Articles

Treatment of Relapsed or Refractory Non-Hodgkin’s Lymphoma (NHL) or Hodgkin’s Disease (HD) with High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (HSCT) Using a Novel Mitoxantrone-Containing Preparative Regimen.

Leslie Andritsos, MD, Wendy Suhre, Mark Nahirny, Ellen Chase, Michael Carroll, M.D., Jennifer Christian, Thomas P. Miller, MD, Andrew M. Yeager, M.D.

Blood (2006) 108 (11): 5264.

https://doi.org/10.1182/blood.V108.11.5264.5264

Published: 2006

Journal Articles

Increased Risk of Non-Relapse Mortality within One Year after Autologous Stem Cell Transplant in Older Adults with Lymphoma.

Matt Kalaycio, M.D., Brad Pohlman, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Kristie Summers, Brian J. Bolwell, M.D., Lisa Rybicki, Elizabeth Kuckowski

Blood (2004) 104 (11): 5111.

https://doi.org/10.1182/blood.V104.11.5111.5111

Published: 2004

NARROW

Genetic Duplication of Tissue Factor Leads to Partial Specialization of Function in Zebrafish

Safety of Caplacizumab in Patients Without Documented Severe ADAMTS13 Deficiency During the HERCULES Study

Antithrombotic Therapy Management in Patients with Inherited Bleeding Disorders and Ischaemic Heart Disease: A Single-Center Experience

Factors Influencing Incidence of Supraventricular Arrhythmias during and after Autologous Stem Cell Transplant in Multiple Myeloma

Comparative Effectiveness of Different Strategies for Monitoring Neonates on Extra Corporeal Membrane Oxygenation (ECMO)

Mantle cell lymphoma presenting as cardiac tamponade

Rh-Positive Fresh Frozen Plasma (FFP) Therapy Can Induce Cross-Reactive Immune Response to Red Blood Cell (RBC) Self-Antigen in Rh-Negative Patients Having Existing Alloimmunization to Rh-Antigen D

Long-Term Outcome Of Adolescents and Young Adults (AYA) After Autologous Transplantation For Lymphoma; Single Center Experience With Bu-CY-VP16 Conditioning Therapy

Rare Blast Phase (BP) Phenotypes of Chronic Myeloid Leukemia (CML)

Cytarabine Induced Pericardial Tamponade

Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP).

Clinical Development of MGCD0103, An Isotype-Selective HDAC Inhibitor: Pericarditis/Pericardial Effusion in the Context of Overall Safety and Efficacy.

Romidepsin (depsipeptide) Induces Clinically Significant Responses in Treatment-Refractory CTCL: An International, Multicenter Study.

T Cell Blast Phase (T-BP) of Chronic Myelogenous Leuikemia (CML).

Megakaryocytic Blast Phase (M-BP) of Chronic Myelogenous Leukemia (CML).

Treatment of Relapsed or Refractory Non-Hodgkin’s Lymphoma (NHL) or Hodgkin’s Disease (HD) with High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (HSCT) Using a Novel Mitoxantrone-Containing Preparative Regimen.

Increased Risk of Non-Relapse Mortality within One Year after Autologous Stem Cell Transplant in Older Adults with Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only